Le JDB : L'entretien de Christophe Douat (Medincell)

from Le Journal des Biotechs · host BOURSORAMA

L'entretien est consacré à Christophe Douat, président du directoire de Medincell. Il revient notamment sur les résultats de phase 3 encourageants de son candidat-médicament mdc-IRM publiés par son partenaire Teva.Hébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Episode metadata supplied by the publisher feed · Published Nov 4, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

Le JDB : L'entretien de Christophe Douat (Medincell)

0:00 19:42

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Le Journal des Biotechs?

This episode is 19 minutes long.

When was this Le Journal des Biotechs episode published?

This episode was published on November 4, 2021.

Can I download this Le Journal des Biotechs episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!